Insider: SING GEORGE L Director - REGENERON PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 26,349 | 1,000 | 27,349 |
| Value | $14,695,627.77 | $557,730.00 | $15,253,357.77 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/26/2024 | DDS | 500 | Direct | COM | $995.00 | $497,500.00 | 26,349 |
| 02/26/2024 | DDS | 500 | Direct | COM | $990.00 | $495,000.00 | 26,349 |
| 02/23/2024 | DDS | 500 | Direct | COM | $985.00 | $492,500.00 | 26,349 |
| 02/22/2024 | DDS | 1,000 | Direct | COM | $970.00 | $970,000.00 | 26,349 |
| 02/22/2024 | DDS | 1,000 | Direct | COM | $960.00 | $960,000.00 | 26,349 |
| 02/22/2024 | DDS | 1,000 | Direct | COM | $965.00 | $965,000.00 | 26,349 |
| 02/09/2024 | DDS | 500 | Direct | COM | $955.00 | $477,500.00 | 26,349 |
| 02/08/2024 | DDS | 500 | Direct | COM | $945.00 | $472,500.00 | 26,349 |
| 02/28/2022 | DDS | 1,000 | Direct | COM | $617.00 | $617,000.00 | 26,049 |
| 02/28/2022 | DDS | 1,000 | Direct | COM | $614.00 | $614,000.00 | 27,049 |
| 02/25/2022 | DDS | 2,000 | Direct | COM | $621.00 | $1,242,000.00 | 28,049 |
| 11/22/2021 | DDS | 1,000 | Direct | COM | $655.00 | $655,000.00 | 30,858 |
| 11/22/2021 | DDS | 1,000 | Direct | COM | $660.00 | $660,000.00 | 29,858 |
| 11/19/2021 | DDS | 1,000 | Direct | COM | $655.00 | $655,000.00 | 31,858 |
| 11/18/2021 | DDS | 4,000 | Direct | COM | $650.00 | $2,600,000.00 | 32,858 |
| 11/16/2021 | DDS | 2,000 | Direct | COM | $650.00 | $1,300,000.00 | 40,858 |
| 11/16/2021 | DDS | 2,000 | Direct | COM | $658.79 | $1,317,580.00 | 38,858 |
| 11/16/2021 | DDS | 2,000 | Direct | COM | $660.00 | $1,320,000.00 | 36,858 |
| 11/16/2021 | DDS | 750 | Indirect | COM | $650.00 | $487,500.00 | 1,000 |
| 08/30/2021 | DDS | 500 | Direct | COM | $675.00 | $337,500.00 | 42,858 |
| 08/30/2021 | DDS | 500 | Direct | COM | $670.00 | $335,000.00 | 43,358 |
| 08/30/2021 | DDS | 250 | Indirect | COM | $670.00 | $167,500.00 | 750 |
| 08/30/2021 | DDS | 300 | Indirect | COM | $672.00 | $201,600.00 | 1,750 |
| 08/26/2021 | DDS | 150 | Indirect | COM | $672.00 | $100,800.00 | 1,000 |
| 08/16/2021 | DDS | 705 | Direct | COM | $630.00 | $444,150.00 | 43,858 |
| 1 2 3 4 5 6 Next Last You are at page 1 of 6 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research